Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells …

V Nayak, S Patra, KRB Singh, B Ganguly… - Environmental …, 2023 - Elsevier
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. These mutations across different types of cancer lead to …
被引用次数：9 相关文章

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells …

V Nayak, S Patra, KRB Singh… - Environmental …, 2023 - ui.adsabs.harvard.edu
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. These mutations across different types of cancer lead to …

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells …

V Nayak, S Patra, KR Singh, B Ganguly… - Environmental …, 2023 - europepmc.org
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. Mutations in commonly affected genes across different …

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells …

V Nayak, S Patra, KR Singh, B Ganguly… - Environmental … - pubmed.ncbi.nlm.nih.gov
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. Mutations in commonly affected genes across different …

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: harnessing diagnostic potential of CRISPR-Cas & engineered CAR T-cells …

V Nayak, S Patra, KRB Singh, B Ganguly, DN Kumar… - 2023 - cabidigitallibrary.org
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. These mutations across different types of cancer lead to …

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells …

V Nayak, S Patra, KRB Singh… - Environmental …, 2023 - ui.adsabs.harvard.edu
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. These mutations across different types of cancer lead to …